Kohjin Bio Co., Ltd. (TYO:177A)

Kohjin Bio Revenue

In the fiscal year ending March 31, 2026, Kohjin Bio had annual revenue of 4.94B JPY, down -5.13%. Kohjin Bio had revenue of 1.15B in the quarter ending March 31, 2026, a decrease of -10.52%.

• Revenue: 4.94B
• Revenue Growth: -5.13%
• P/S Ratio: 1.05
• Revenue / Employee: 29.57M
• Employees: 167
• Market Cap: 5.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.94B	-267.00M	-5.13%
Mar 31, 2025	5.21B	436.00M	9.14%
Mar 31, 2024	4.77B	28.00M	0.59%
Mar 31, 2023	4.74B	795.00M	20.14%
Mar 31, 2022	3.95B	809.83M	25.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error